Indian gooseberry shows promise as a natural cholesterol-lowering herb
04/10/2019 // Michelle Simmons // Views

A study published in the journal BMC Complementary and Alternative Medicine revealed that the Indian gooseberry (Emblica officinalis) can potentially lower cholesterol and triglyceride levels. In the study, researchers from India examined the efficacy of the Indian gooseberry in individuals with dyslipidemia.

  • Dyslipidemia is one of the most common risk factors for the development of atherosclerosis and other heart disorders. It is characterized by high levels of triglycerides and total cholesterol in the blood.
  • In conducting the study, the researchers recruited 98 participants and divided them into two groups: a treatment and a placebo group. Participants in the treatment group received 500 milligrams (mg) of the Indian gooseberry extract, while the other group received a placebo capsule.
  • The extract and placebo were given twice every day for 12 weeks.
  • After the treatment period, the researchers measured the lipid profiles of the participants.
  • They also looked at the effect of the Indian gooseberry extract on other markers of cardiovascular disease, as well as fasting blood glucose and Coenzyme Q10 (CoQ10), which acts as an antioxidant.
  • Results showed that the Indian gooseberry treatment significantly improved the lipid profiles of the participants.
  • It reduced levels of total cholesterol, triglycerides, low-density lipoprotein (LDL) cholesterol, and very low-density lipoprotein (VLDL) cholesterol.
  • In addition, the markers of cardiovascular disease were reduced by the Indian gooseberry extract.
  • The researchers also observed a general trend of fasting blood glucose reduction, suggesting a potential hypoglycemic effect.
  • Indian gooseberry also did not affect CoQ10 levels, unlike statin drugs.

In conclusion, Indian gooseberry can be used as a safe and effective way to treat dyslipidemia and improve cardiovascular health.

Read the full text of the study at this link.

To read more studies on the health benefits of the Indian gooseberry, visit NaturalCures.news.

Journal Reference:

Upadya H, Prabhu S, Prasad A, Subramanian D, Gupta S, Goel A. A RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED, MULTICENTER CLINICAL TRIAL TO ASSESS THE EFFICACY AND SAFETY OF EMBLICA OFFICINALIS EXTRACT IN PATIENTS WITH DYSLIPIDEMIA. BMC Complementary and Alternative Medicine. 22 January 2019; 19:27. DOI: 10.1186/s12906-019-2430-y



Take Action:
Support Natural News by linking to this article from your website.
Permalink to this article:
Copy
Embed article link:
Copy
Reprinting this article:
Non-commercial use is permitted with credit to NaturalNews.com (including a clickable link).
Please contact us for more information.
Free Email Alerts
Get independent news alerts on natural cures, food lab tests, cannabis medicine, science, robotics, drones, privacy and more.
App Store
Android App
eTrust Pro Certified

This site is part of the Natural News Network © 2022 All Rights Reserved. Privacy | Terms All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing International, LTD. is not responsible for content written by contributing authors. The information on this site is provided for educational and entertainment purposes only. It is not intended as a substitute for professional advice of any kind. Truth Publishing assumes no responsibility for the use or misuse of this material. Your use of this website indicates your agreement to these terms and those published here. All trademarks, registered trademarks and servicemarks mentioned on this site are the property of their respective owners.

This site uses cookies
Natural News uses cookies to improve your experience on our site. By using this site, you agree to our privacy policy.
Learn More
Close
Get 100% real, uncensored news delivered straight to your inbox
You can unsubscribe at any time. Your email privacy is completely protected.